Delivery Order SPE2DB20D2014-SPE2DB25FB09L

Award Date 2/18/25
Potential Completion Date 2/19/25
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,546.03 firm fixed-price delivery order is for the supply of Telmisartan-HCTZ 80-25 mg tablets, a medication used to treat high blood pressure. The contract has an ultimate completion date of November 27, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,160.70 firm fixed-price delivery order is for the supply of Telmisartan 80 mg tablets, a cardiovascular medication. The contract has an ultimate completion date of November 20, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,065.92 firm-fixed-price delivery order is for the supply of Telmisartan 80 mg tablets, a hypertension medication, to support military treatment facilities and other government healthcare programs. The contract has an ultimate completion date of August 9, 2024. AmerisourceBergen holds several Indefinite...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,915.95 firm-fixed-price delivery order is for the supply of Telmisartan 80 mg tablets. It is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for AmerisourceBergen...
This federal contract award, valued at $5,754.94, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Telmisartan 80 mg tablets, a cardiovascular medication, and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $1,707.54, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4,567,173,826 units of Telmisartan 20 mg tablets, a cardiovascular medication. The contract has an ultimate completion date of February 6, 2025 and is a firm fixed-price award. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,713.96 delivery order contract is for the supply of Telmisartan 20 mg tablets, a cardiovascular medication. The contract has a firm fixed price and an ultimate completion date of July 11, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $4,255.27, is for the delivery of Telmisartan-HCTZ 80-25 mg tablets. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of July 29, 2024. AmerisourceBergen has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award, valued at $1,139.70, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Telmisartan 80 mg tablets, a medication used to treat high blood pressure. The award has an ultimate completion date of December 4, 2024 and is structured as a Firm Fixed Price Delivery Order. The contract is not designated with a set-aside requirement,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,590.05 firm fixed-price delivery order is for the supply of 4566371858 TELMISARTAN 80 MG TABLET 30S, a cardiovascular medication. The contract has an ultimate completion date of November 8, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB25FB09L
    Delivery Order

This federal contract award, valued at $1,614.87, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Telmisartan 80 mg tablets, a medication used to treat high blood pressure. The contract has an ultimate completion date of February 19, 2025 and is a Firm Fixed Price Delivery Order, with no set-aside designation.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 5/20/25, 1:52 PM